Glyasperin F

Glyasperin F
Product Name Glyasperin F
CAS No.: 145382-61-2
Catalog No.: CFN94013
Molecular Formula: C20H18O6
Molecular Weight: 354.35 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Targets: NO
Source: The roots of Glycyrrhiza aspera Pall.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $318/5mg
Glyasperin F has antinociceptive, and anti-inflammatory effects, it could inhibit NO production in RAW 264.7 macrophages to some extent. Glyasperin F displayed cytotoxic effects against the four tested cancer cell lines with IC50values below 85 μM.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Pharmaceuticals (Basel).2021, 14(7):633.
  • J Chromatogr B Analyt Technol Biomed Life Sci.2019, 1124:323-330
  • J Sep Sci.2018, 41(7):1682-1690
  • Fitoterapia.2021, 153:104995.
  • Cell Biochem Funct.2018, 36(6):303-311
  • Korean J. of Food Sci. and Tech2016, 172-177
  • J Hematol Oncol.2018, 11(1):112
  • J Chromatogr A.2017, 1518:46-58
  • Phytother Res.2020, 34(4):788-795.
  • Korean Journal of Pharmacognosy2018, 49(1):76-83
  • Dihydrolicoisoflavone

    Catalog No: CFN95073
    CAS No: 164163-92-2
    Price: $333/5mg
    5,7,2',4'-Tetrahydroxy-8,3'-di(gamma,gamma-dimethylallyl)-isoflavanone

    Catalog No: CFN95084
    CAS No: 141846-47-1
    Price: $413/5mg
    5-Deoxycajanin

    Catalog No: CFN97240
    CAS No: 7622-53-9
    Price: Inquiry(manager@chemfaces.com)
    Dalbergioidin

    Catalog No: CFN97931
    CAS No: 30368-42-4
    Price: Inquiry(manager@chemfaces.com)
    2'-Hydroxygenistein

    Catalog No: CFN99257
    CAS No: 1156-78-1
    Price: Inquiry(manager@chemfaces.com)
    Lupinalbin A

    Catalog No: CFN80045
    CAS No: 98094-87-2
    Price: Inquiry(manager@chemfaces.com)
    Barpisoflavone A

    Catalog No: CFN97861
    CAS No: 101691-27-4
    Price: Inquiry(manager@chemfaces.com)
    Cajanin

    Catalog No: CFN98419
    CAS No: 32884-36-9
    Price: $318/5mg
    Homoferreirin

    Catalog No: CFN97891
    CAS No: 482-01-9
    Price: Inquiry(manager@chemfaces.com)
    Sophoraisoflavone A

    Catalog No: CFN96513
    CAS No: 117204-81-6
    Price: Inquiry(manager@chemfaces.com)
    Chinese Traditional and Herbal Drugs, 2016.
    Study on active constituents from Glycyrrhizae Radix et Rhizoma against NO production in LPS-induced RAW264.7 macrophages.[Reference: WebLink]
    To study the anti-inflammatory constituents in Glycyrrhizae Radix et Rhizoma.
    METHODS AND RESULTS:
    The compounds were isolated and purified by means of macroporous resin, ODS column chromatography, and semi-preparative HPLC. And their structures were identified by LC-MS, 1H-NMR, and 13C-NMR. The anti-inflammatory activities of the compounds were evaluated on LPS-induced NO production in RAW 264.7 macrophages.Their structures were identified as liquiritin(1), liquiritin apioside(2), isoliquiritin(3), isoliquiritin apioside(4), sophoraisoflavone A(5), Glyasperin F(6), glabrone(7), glabridin(8), licoflavonol(9), and glyasperin D(10).
    CONCLUSIONS:
    Compounds 1, 3, 5, 6, 8, and 9 could inhibit NO production in RAW 264.7 macrophages to some extent. And the anti-inflammatory effects of compounds 5, 6, and 9 are first reported in this work.
    Bmc Complementary & Alternative Medicine, 2018, 18(1):36.
    Cytotoxicity of seputhecarpan D, thonningiol and 12 other phytochemicals from African flora towards human carcinoma cells.[Reference: WebLink]
    Despite the remarkable progress in cancer therapy in recent years, this disease still remains a serious public health concern. The use of natural products has been and continues to be one of the most effective ways to fight malignancies. The cytotoxicity of 14 compounds from African medicinal plants was evaluated in four human carcinoma cell lines and normal fibroblasts. The tested samples included: β-spinasterol (1), friedelanone (2), 16β-hydroxylupeol (3), β-amyrin acetate (4), lupeol acetate (5), sequoyitol (6), rhamnitrin (7), europetin 3-O-rhamnoside (8), thonningiol (9), Glyasperin F (10), seputhecarpan B (11), seputhecarpan C (12), seputhecarpan D (13) and rheediaxanthone A (14).
    METHODS AND RESULTS:
    The neutral red uptake (NR) assay was used to evaluate the cytotoxicity of samples; caspase-Glo assay, flow cytometry for cell cycle analysis and mitochondrial membrane potential (MMP) as well as spectrophotometry to measure levels of reactive oxygen species (ROS) were performed to detect the mode of action of compounds 9 and 13 in MCF-7 breast adenocarcinoma cells.Compounds 3, 9-13 displayed cytotoxic effects against the four tested cancer cell lines with IC50values below 85 μM. Compounds 9 and 13 had IC50values below 10 μM in 4/4 and 3/4 tested cell lines respectively. The IC50values varied from 0.36 μM (against MCF7 cells) to 5.65 μM (towards colon carcinoma DLD-1 cells) for 9, from 9.78 μM (against MCF7 cells) to 67.68 μM (against HepG2 cells) for 13 and 0.18 μM (towards HepG2 cells) to 72 μM (towards Caco-2 cells) for the reference drug, doxorubicin. Compounds 9 and 13 induced cell cycle arrest in Go/G1 whilst doxorubicin induced arrest in G2/M. The two molecules (9 and 13) also induced apoptosis in MCF-7 cells through activation of caspases 3/7 and 9 as well as enhanced ROS production.
    CONCLUSIONS:
    Compounds 9 and 13 are good cytotoxic phytochemicals that should be explored more in future to develop a cytotoxic drug to fight human carcinoma.
    Bmc Complementary & Alternative Medicine, 2018, 18(1):36.
    Cytotoxicity of seputhecarpan D, thonningiol and 12 other phytochemicals from African flora towards human carcinoma cells.[Reference: WebLink]
    Despite the remarkable progress in cancer therapy in recent years, this disease still remains a serious public health concern. The use of natural products has been and continues to be one of the most effective ways to fight malignancies. The cytotoxicity of 14 compounds from African medicinal plants was evaluated in four human carcinoma cell lines and normal fibroblasts. The tested samples included: β-spinasterol (1), friedelanone (2), 16β-hydroxylupeol (3), β-amyrin acetate (4), lupeol acetate (5), sequoyitol (6), rhamnitrin (7), europetin 3-O-rhamnoside (8), thonningiol (9), Glyasperin F (10), seputhecarpan B (11), seputhecarpan C (12), seputhecarpan D (13) and rheediaxanthone A (14).
    METHODS AND RESULTS:
    The neutral red uptake (NR) assay was used to evaluate the cytotoxicity of samples; caspase-Glo assay, flow cytometry for cell cycle analysis and mitochondrial membrane potential (MMP) as well as spectrophotometry to measure levels of reactive oxygen species (ROS) were performed to detect the mode of action of compounds 9 and 13 in MCF-7 breast adenocarcinoma cells.Compounds 3, 9-13 displayed cytotoxic effects against the four tested cancer cell lines with IC50values below 85 μM. Compounds 9 and 13 had IC50values below 10 μM in 4/4 and 3/4 tested cell lines respectively. The IC50values varied from 0.36 μM (against MCF7 cells) to 5.65 μM (towards colon carcinoma DLD-1 cells) for 9, from 9.78 μM (against MCF7 cells) to 67.68 μM (against HepG2 cells) for 13 and 0.18 μM (towards HepG2 cells) to 72 μM (towards Caco-2 cells) for the reference drug, doxorubicin. Compounds 9 and 13 induced cell cycle arrest in Go/G1 whilst doxorubicin induced arrest in G2/M. The two molecules (9 and 13) also induced apoptosis in MCF-7 cells through activation of caspases 3/7 and 9 as well as enhanced ROS production.
    CONCLUSIONS:
    Compounds 9 and 13 are good cytotoxic phytochemicals that should be explored more in future to develop a cytotoxic drug to fight human carcinoma.
    Journal of the Korean Society for Applied Biological Chemistry, 2013, 56(5):541–545.
    Antinociceptive effect of glyasperin F isolated from Glycyrrhiza inflata in mice.[Reference: WebLink]
    Antinociceptive effect of Glyasperin F isolated from Glycyrrhiza inflata extract (GIE) in ICR mice was studied.
    METHODS AND RESULTS:
    Oral administration of GIE (1–100 mg/kg) caused a dose-dependent reduction in acetic acid-induced writhing responses. To identify the active antinociceptive compound from the GIE, sub-fractions were obtained from the EtOAc layer of GIE by using a medium pressure liquid chromatography. From the sub-fractions obtained, the sub-fraction, which, when administered orally (10 mg/kg) showed an antinociceptive effect in both the writhing test and second phase of the formalin test was identified as Glyasperin F using NMR and MS analyses. Finally, the antinociceptive effect of Glyasperin F in mouse models of pain was confirmed. Orally administered Glyasperin F (0.1–10mg/kg) showed a dose-dependent antinociceptive effect in both the writhing test and second phase of the formalin test.
    CONCLUSIONS:
    Taken together, Glyasperin F isolated from the GIE may be used as a leading compound for further studies on pain and as a new drug derived from natural products for pain therapy.
    Chinese Traditional and Herbal Drugs, 2010, 12(6):505-515.
    Chemical constituents in stem bark of Morus cathayana.[Reference: WebLink]
    To study chemical constituents in the stem bark of Morus cathayana.
    METHODS AND RESULTS:
    The constituents were separated and purified with chromatographic methods and their structures were elucidated by spectroscopic methods and chemical analyses. All the compounds were tested for their cytotoxicities. Eleven compounds, Glyasperin F (1), broussoflavonol F (2), lespedezaflavanone C (3), isolicoflavonol (4), sanggenol B (5), sanggenol L (6), sanggenol D (7), sanggenol G (8), sanggenol A (9), dihydroquercetin (10), and quercetin (11), were isolated from the stem bark of M. cathayana.
    CONCLUSIONS:
    Compounds 1-3 are isolated from Morus L. for the first time. Compounds 2, 4-6, and 9 exhibit moderate cytotoxic activities against five human cancer cells with the IC50 value of 0.41-7.2 μg/mL.
    Suchilactone

    Catalog No: CFN95010
    CAS No: 50816-74-5
    Price: $338/5mg
    Buddlenoid A

    Catalog No: CFN95025
    CAS No: 142750-32-1
    Price: $368/5mg
    Pueroside B

    Catalog No: CFN95141
    CAS No: 100692-54-4
    Price: $288/10mg
    Arisanschinin E

    Catalog No: CFN95221
    CAS No: 1333378-33-8
    Price: Inquiry(manager@chemfaces.com)
    Ginsenoside Rd2 (Quinquenoside L10)

    Catalog No: CFN95231
    CAS No: 83480-64-2
    Price: $318/10mg
    Tigloylgomisin O

    Catalog No: CFN95237
    CAS No: 130855-74-2
    Price: $368/5mg
    New compound 5

    Catalog No: CFN95258
    CAS No: N/A
    Price: $413/5mg
    ZP-amide C

    Catalog No: CFN95362
    CAS No: 412316-38-2
    Price: $413/5mg
    10-O-trans-p-coumaroylscandoside

    Catalog No: CFN95391
    CAS No: 870785-25-4
    Price: $318/10mg
    Oleracein E

    Catalog No: CFN95441
    CAS No: 1021950-79-7
    Price: $318/5mg